期刊文献+

慢性尿酸性肾病35例临床分析

Clinical analysis of 35 patients with gouty nephropathy
下载PDF
导出
摘要 目的探讨慢性尿酸性肾病的临床特点及疗效。方法收集本院肾内科住院确诊为慢性尿酸性肾病患者35例,回顾性分析其临床特点、伴发病情况及治疗。结果35例中,男31例,女4例;平均年龄61.5岁,平均病程12.3年。有痛风家族史4例。肾外表现,伴急性痛风性关节炎26例,伴痛风结节10例。血尿23例,蛋白尿24例,低比重尿15例,慢性肾功能不全27例。伴发病情况,高脂血症18例,高血压25例。治疗上,急性期23例使用非甾体类消炎药,10例使用秋水仙碱,8例使用激素。慢性期25例应用别嘌呤醇降尿酸,用立加利仙7例促尿酸排泄。降压治疗10例使用科素亚。10例最终达终末期肾病,予透析治疗。结论痛风发病率呈上升趋势,应重视慢性高尿酸血症导致的肾脏损害。 Objective To analyze clinical characteristics and therapy of gouty nephropathy. Methods The clinical data of 35 patients with gouty nephropathy were retrospectively analyzed and summarized. Results Thirty-five cases included 31 cases of men and four cases of women. Their average age were 61.5 years old, and the average duration were 12.3 years. There were four cases of a family history of gout. Outside the renal manifestations, acute gouty arthritis with 26 cases and 10 cases of tophus were observed. Among these patients, 23 cases had hematuria, 24 cases had proteinuria, and 15 had low gravity urine. Chronic renal insufficiency in 27 cases. Eighteen cases were accompanied with hyperlipidemia, 25 with hypertension. 23 cases were used non steroidal anti-inflammatory drugs for controlling acute inflammatory, 10 cases were used colchicine, eight cases were used corticosteroids. Chronic phase 25 cases were used with allopurinol for interrupt uric synthesis, seven cases were used with benzbromarone. Losartan used for the treatment of hypertension in 10 cases. 10 cases developed end stage renal disease and got dialysis treatment. Conclusion The incidence of gout has been increasing. We should pay attention to kidney disease caused by chronic hyperuricemia.
出处 《福建医药杂志》 CAS 2009年第6期18-20,共3页 Fujian Medical Journal
关键词 痛风 高尿酸血症 慢性尿酸性肾病 Gout Hyperuricemia Gout nephropathy
  • 相关文献

参考文献10

  • 1陈香美,吴镝.高尿酸血症肾病[M]//王海燕.肾脏病学.第3版.北京:人民卫生出版社,2008:1435-1454.
  • 2蒋季杰.尿酸肾病[M]//叶任高.临床肾脏病学.第2版.北京:人民卫生出版社,2007:312-319.
  • 3施桂英.痛风——降尿酸治疗的新策略[J].中华风湿病学杂志,2007,11(3):129-131. 被引量:21
  • 4Annemans L, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005 [J]. Ann Rheum Dis, 2008, 67 (7): 960-966.
  • 5苗志敏,赵世华,王颜刚,李长贵,王忠超,陈颖,陈新焰,阎胜利.山东沿海居民高尿酸血症及痛风的流行病学调查[J].中华内分泌代谢杂志,2006,22(5):421-425. 被引量:207
  • 6Mohandas R, Johnson RJ. Uric acid levels increase risk for newonset kidney disease [J]. J Am Soc Nephrol, 2008, 19 (12): 2251-2253.
  • 7Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk [J]. N Engl J Med, 2008, 359 (17): 1811-21.
  • 8Dalbeth N, Kumar S, Stamp L, et al. Dose adjustment of atlopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout [J]. J Rheumatol, 2006, 33 (8): 1646-1650.
  • 9Fels E, Sundy JS. Refractory gout: what is it and what to do about it? [J]. Curr Opin Rheumatol, 2008, 20 (2): 198-202.
  • 10Janssens HJ, Janssen M, van de Lisdonk EH, et al. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial [J]. Lancet, 2008, 371:1854-1860.

二级参考文献27

共引文献227

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部